MSB 2.41% $1.49 mesoblast limited

Did they over enroll this trial? If so, maybe the initial...

  1. 280 Posts.
    lightbulb Created with Sketch. 182
    Did they over enroll this trial? If so, maybe the initial patient target were treated not long after enrollment and thats what they will use. But through social media I know that patients in the trial were still receiving dosings in July.

    If an annocement was forth coming would management have included it as an upcoming milestone during recent presentations?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.